Abstract

This controlled cohort study investigates the prevalence of Type-2 diabetes following gastric bypass surgery in a Swedish population. The study included number participants who underwent gastric bypass surgery between dates and dates, compared with a matched control group. Participants were assessed for diabetes prevalence using medical records and follow-up examinations over a duration period. Results indicated a significant reduction in the prevalence of Type-2 diabetes post-surgery compared to the control group. Percentage of participants achieved remission or improvement in diabetes status, as evidenced by reduced medication use or improved glycemic control. Factors such as weight loss, changes in insulin sensitivity, and alterations in gut hormone secretion post-surgery were considered in the context of diabetes outcomes. These findings underscore the beneficial impact of gastric bypass surgery on Type-2 diabetes management and provide valuable insights into the mechanisms underlying metabolic improvements following surgical intervention. Further research is needed to elucidate long-term outcomes and optimize patient selection and management strategies for individuals with Type-2 diabetes considering bariatric surgery.